In CRC cells, SNHG5 is predominantly localized in the cytoplasm, where it binds to the double-stranded RNA-binding protein Staufen1 (STAU1) and inhibits the Staufen-mediated mRNA decay (SMD) pathway. Here, SNHG5 is linked to colorectal carcinoma.